Early pharmacokinetics of low dosage mycophenolate exposure in Thai kidney transplant recipients

Int J Clin Pharm. 2019 Aug;41(4):1047-1055. doi: 10.1007/s11096-019-00848-w. Epub 2019 May 25.

Abstract

Background The effects of mycophenolic acid exposure in the early period after transplantation on clinical outcomes have been reported; however, mycophenolic acid exposure in the early period after transplantation in Asian kidney transplant recipients who receive 1.5 g/d mycophenolate mofetil has never been investigated. Objective To determine mycophenolic acid exposure on day 3 post-transplantation in kidney transplant recipiens who receive 1.5 g/d mycophenolate mofetil. The effects of the reduced renal function on mycophenolic acid area under the concentration-time curve (AUC) and the achievement of the target AUC on the incidence of biopsy proven acute rejection during the first month post-transplantation were also evaluated. Setting A university hospital Method Blood samples and 24-h urine were collected on day 3 post-transplantation. Main outcome measures The mycophenolic acid AUC was calculated by linear trapezoidal rule and compared with the target of 45 mg*h/L. Results Of 42 Thai kidney transplant recipiens, the mean mycophenolic acid AUC of 45.1 mg*h/L (SD 14.7) was comparable to the AUC target (P = 0.962). Significant differences of the mycophenolic acid AUC were observed between patients with urine output of < 2400 mL and those with urine output ≥ 2400 mL (35.3 ± 6.6 and 47.4 ± 15.2, respectively; P = 0.002), and between patients with 24-h measured CrCl < 25 mL/min and those with CrCl ≥ 25 mL/min (38.0 (29.0, 42.2) and 49.2 ± 14.0, respectively; P = 0.017). Proportions of overall biopsy proven acute rejection among patients with mycophenolic acid AUC of < 45 and ≥ 45 mg*h/L were comparable (20.0% and 23.5%, respectively; P = 1.000). Conclusions After the starting dosage of 1.5 g/d mycophenolate mofetil, the mean mycophenolic acid AUC on day 3 post-kidney transplantation is comparable with the target of 45 mg*h/L. Severely reduced renal function significantly influences mycophenolic acid exposure.

Keywords: Kidney transplantation; Mycophenolate mofetil; Mycophenolic acid; Pharmacokinetics; Renal function.

Publication types

  • Clinical Trial

MeSH terms

  • Adolescent
  • Adult
  • Enzyme Inhibitors / blood
  • Enzyme Inhibitors / pharmacokinetics
  • Enzyme Inhibitors / therapeutic use
  • Female
  • Graft Rejection / drug therapy
  • Graft Rejection / epidemiology*
  • Humans
  • Kidney Transplantation / statistics & numerical data*
  • Male
  • Middle Aged
  • Mycophenolic Acid / blood
  • Mycophenolic Acid / pharmacokinetics*
  • Thailand / epidemiology
  • Transplant Recipients / statistics & numerical data*
  • Young Adult

Substances

  • Enzyme Inhibitors
  • Mycophenolic Acid